BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32726298)

  • 1. Cortical atrophy mediates the accumulating effects of vascular risk factors on cognitive decline in the Alzheimer's disease spectrum.
    Wang Q; He C; Zhu Y; Zhang Q; Zhang Z; Xie C
    Aging (Albany NY); 2020 Jul; 12(14):15058-15076. PubMed ID: 32726298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
    Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Deep Gray Matter Changes and Neurocognitive Function in Mild Cognitive Impairment and Alzheimer's Disease: A Tensor-Based Morphometric MRI Study.
    Tuokkola T; Karrasch M; Koikkalainen J; Parkkola R; Lötjönen J; Löyttyniemi E; Hurme S; Rinne JO
    Dement Geriatr Cogn Disord; 2019; 48(1-2):68-78. PubMed ID: 31514198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
    Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left dorsolateral prefrontal cortex atrophy is associated with frontal lobe function in Alzheimer's disease and contributes to caregiver burden.
    Matsuoka K; Yasuno F; Hashimoto A; Miyasaka T; Takahashi M; Kiuchi K; Iida J; Kichikawa K; Kishimoto T
    Int J Geriatr Psychiatry; 2018 May; 33(5):703-709. PubMed ID: 29280514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
    Kimura A; Yoshikura N; Hayashi Y; Inuzuka T
    J Alzheimers Dis; 2018; 61(2):581-588. PubMed ID: 29171996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathomechanisms of atrophy in insular cortex in Alzheimer's disease.
    Moon Y; Moon WJ; Han SH
    Am J Alzheimers Dis Other Demen; 2015 Aug; 30(5):497-502. PubMed ID: 25596207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Callosal atrophy correlates with temporal lobe volume and mental status in Alzheimer's disease.
    Black SE; Moffat SD; Yu DC; Parker J; Stanchev P; Bronskill M
    Can J Neurol Sci; 2000 Aug; 27(3):204-9. PubMed ID: 10975532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Risk Factors and Brain Health in Aging: Insights from a Community-Based Cohort Study.
    Wang W; Yang Y; Sang F; Chen Y; Li X; Chen K; Wang J; Zhang Z
    J Alzheimers Dis; 2024; 99(4):1361-1374. PubMed ID: 38788079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease.
    Dicks E; van der Flier WM; Scheltens P; Barkhof F; Tijms BM;
    Neurobiol Aging; 2020 Oct; 94():71-80. PubMed ID: 32585492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of vascular risk factors on cognitive decline in patients with Alzheimer's disease.
    Blom K; Vaartjes I; Peters SA; Koek HL
    Maturitas; 2014 Sep; 79(1):96-9. PubMed ID: 25059438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients.
    Xie C; Bai F; Yuan B; Yu H; Shi Y; Yuan Y; Wu D; Zhang ZS; Zhang ZJ
    Psychol Med; 2015 Jul; 45(9):1799-810. PubMed ID: 25511078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum.
    Amaefule CO; Dyrba M; Wolfsgruber S; Polcher A; Schneider A; Fliessbach K; Spottke A; Meiberth D; Preis L; Peters O; Incesoy EI; Spruth EJ; Priller J; Altenstein S; Bartels C; Wiltfang J; Janowitz D; Bürger K; Laske C; Munk M; Rudolph J; Glanz W; Dobisch L; Haynes JD; Dechent P; Ertl-Wagner B; Scheffler K; Kilimann I; Düzel E; Metzger CD; Wagner M; Jessen F; Teipel SJ
    Neuroimage Clin; 2021; 29():102533. PubMed ID: 33360018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Default Mode Network Connectivity Moderates the Relationship Between the APOE Genotype and Cognition and Individualizes Identification Across the Alzheimer's Disease Spectrum.
    Zhu Y; Gong L; He C; Wang Q; Ren Q; Xie C;
    J Alzheimers Dis; 2019; 70(3):843-860. PubMed ID: 31282419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.